Advanced Lung Cancer in Patient Smoker with Squamous Cell: Clinical Insights from a US Oncologists’ Survey

Posted by on December 30, 2011 in Market Research

Advanced Lung Cancer in Patient Smoker with Squamous Cell: Clinical Insights from a US Oncologists’ Survey 

Description

A patient specific case scenario on advanced lung cancer in a situation involving a smoker with squamous cell that progresses throughout the report, presented to 158 high-prescribing oncologists for their open responses on clinical decisions. Patient progression reveals:

  • Decisions in treatment and tests through disease stages
  • Factors influencing their decisions
  • Barriers to optimal care
  • Confidence in treatment.

Data has been synthesized to show all responses and direct quotes from the oncologists. This is the primary research for the oncology prescribing data that you are missing – directly from high-prescribing US oncologists on Advanced Lung Cancer.

Treatment decisions for advanced stages of lung cancer are difficult to track as information quickly changes along with the introduction of new products that all have an impact oncologists’ choices. This report is part of a series of oncology reports that allow you to see what is actually happening at the patient level for different types of patients presenting with a wide range of issues in advanced stages of cancer.

This report allows you to:

  • Understand what occurs with actual patients
  • Access the most up-to-date prescribing trends
  • Gain actionable data for developing and improving your market strategies
  • Pinpoint needs of your target audience
  • Focus resources to maximize the effectiveness of your budget
  • Understand where your product fits
  • Understand where your competitor’s product fits
  • Design messages to advance brand performance

Table of Contents

Executive Summary
Chapter 1: Introduction
Table 1: Treatment Options in Advanced Lung Cancer
Chapter 2: Respondent Demographics
Table 2: Eligibility Criteria for Survey Participation
Figure 2.1 Gender of Survey Respondents
Figure 2.2 Years since Medical School Graduation
Figure 2.3 Practice Settings
Figure 2.4 Practices in NCI Cancer Centers
Figure 2.5 Geographic Settings
Figure 2.6 Survey Respondents by State’s Lung Cancer Mortality
Figure 2.7 Number of Physicians in Practice Groups
Figure 2.8 Minimal Acceptable Level of Evidence in Determining Treatment Regimen
Chapter 3: Treatment of a Smoker with Squamous Cell Carcinoma
Figure 3.1 Laboratory studies to be done on the tumor tissue
Figure 3.2 First line chemotherapy regimen
Figure 3.3 Factors Influencing Treatment Decisions
Figure 3.4 Confidence in treating this patient to an optimal outcome
Figure 3.5 Next step in management
Figure 3.6 Subsequent treatment regimen
Figure 3.7 Treatment at next cancer progression
Figure 3.8 Factors influencing treatment decisions
Figure 3.9 Barriers to management of advanced lung cancer
Chapter 4: Summary
Appendix A: Survey Instrument

Related posts:

  1. Advanced Lung Cancer in Patient Light Smoker with Lung Adenocarcinoma: Clinical Insights from a US Oncologists’ Survey
  2. US Oncologist Survey: Optimizing Treatment for Advanced Lung Cancer
  3. US Oncologist Survey: Optimizing Treatment for Large Cell Lymphoma
  4. US Oncologist Survey: Optimizing Treatment for Stage IV Follicular B-Cell Non-Hodgkin’s Lymphoma
  5. US Oncologist Survey: Optimizing Treatment for Advanced Non-Hodgkin’s Lymphoma

Comments are closed.